3-Methyl-1H-indazol-4-ol

Catalog No.: 
ACWNMU481
CAS No.: 
149071-05-6
Molecular Formula: 
C8H8N2O
Molecular Weight: 
148.16
3-Methyl-1H-indazol-4-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$79.00In stockIn stock
250mg98%$136.00In stockIn stock
1g98%$369.00In stockIn stock
5g98%$1617.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-1H-indazol-4-ol
IUPAC Name3-methyl-1H-indazol-4-ol
Molecular FormulaC8H8N2O
Molecular Weight148.16
SMILESOC1=CC=CC2=C1C(C)=NN2
InChI KeyIORFQVZJHMWVSO-UHFFFAOYSA-N
Synonym4-Hydroxy-3-methyl-1H-indazole;1H-Indazol-4-ol, 3-Methyl-;3-methyl-1,2-dihydroindazol-4-one
CAS No.149071-05-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWNMU481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJLQB942 route compound structure diagram
    ACJLQB942699-83-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWNMU481 route product structure diagram
    ACWNMU481149071-05-6In Stock
Inquiry

2. ACWNMU481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAEFV876 route compound structure diagram
    ACAEFV876149071-06-7
  2. Then
  3. ACWNMU481 route product structure diagram
    ACWNMU481149071-05-6In Stock
Inquiry

3. ACWNMU481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAEFV876 route compound structure diagram
    ACAEFV876149071-06-7
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWNMU481 route product structure diagram
    ACWNMU481149071-05-6In Stock
Inquiry

Comments (0)